ALung Technologies recently announced the initiation of patient enrollment in its VENT-AVOID trails with the Minneapolis Heart Institute Foundation. The trial is pivotal in validating the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients who require ventilatory support.
Recent Posts
One year and five companies later, the Translational Sciences team is making a big impact at UPMC Enterprises
Less than 18 months later, that Enterprises team is nearly 20 strong and already seeing …
Read More →
Life Sciences Week Recap: The future of health care is here in Pittsburgh
Pittsburgh Life Sciences Week took place May 13 – May 17 and featured local and …
Read More →